Cochlear implants are the flagship sensory neural prosthetic, enabling improved hearing and speech perception in >1 million patients with hearing loss \cite{zengCelebratingOneMillionth2022}.Despite over three decades of active work and innovations in cochlear implants, hearing performance for complex tasks such as speech-in-noise and music appreciation are still quite limited, putatively due to the challenge of...
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change; this is a preclinical bench-testing study and the device has not yet been tested in humans.
A stable, improved auditory nerve interface could eventually overcome key limitations of current cochlear implants, potentially benefiting over one million hearing-loss patients worldwide.
- 01Novel auditory nerve interface designed to improve on cochlear implant technology was preclinically bench-tested.
- 02Stimulation-stability testing assessed the device's ability to deliver consistent electrical signals over time.
- 03Study is preclinical only; no animal or human implantation data are reported.
- 04Target population cited as >1 million hearing-loss patients currently using cochlear implants.
- 05Results inform future in-vivo and eventual clinical trial design.
The new auditory nerve interface demonstrates stimulation stability in preclinical bench testing.
studypartially supportedThe device is intended to improve upon existing cochlear implant technology for >1 million hearing-loss patients.
press releaseunclear- PMID
- 42818525
- DOI
- 10.21203/rs.3.rs-10887452/v1.
- Publication type
- preprint
- Evidence level
- na
- Population
- Bench/laboratory testing (no biological subjects)
- Intervention
- Novel auditory nerve interface — stimulation-stability and bench testing
- Comparator
- Current cochlear implant technology (implied)
Primary outcomes
Stimulation stability under repeated electrical stimulation; Preclinical bench performance metrics of the auditory nerve interface